108 related articles for article (PubMed ID: 694838)
1. C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis.
Kluft C
Thromb Res; 1978 Aug; 13(2):135-51. PubMed ID: 694838
[No Abstract] [Full Text] [Related]
2. Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.
Kluft C
Haemostasis; 1976; 5(3):136-46. PubMed ID: 12071
[TBL] [Abstract][Full Text] [Related]
3. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
Jespersen J; Kluft C
Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
Kluft C; Cooper P; Jie AF; Lowe GD; Forbes CD; Blamey SL; van de Putte LB
Haemostasis; 1985; 15(2):144-50. PubMed ID: 3874124
[TBL] [Abstract][Full Text] [Related]
5. Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator.
Kluft C
Haemostasis; 1977; 6(6):351-69. PubMed ID: 611048
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and experimental studies of the influence of Cl-inactivator on the euglobulin clot lysis time (author's transl)].
Takeda S; Katoh H; Takaki A; Nouzuka Y; Ohsato K
Rinsho Ketsueki; 1979 Aug; 20(8):879-85. PubMed ID: 502003
[No Abstract] [Full Text] [Related]
7. Sustained fibrinolytic activity in the euglobulin fraction induced by concomitant administration of urokinase and dextran sulphate.
Matsuo O; Kawaguchi T; Kosugi T; Mihara H
Thromb Res; 1978 Dec; 13(6):1125-30. PubMed ID: 749265
[No Abstract] [Full Text] [Related]
8. Effects of dextran sulphate and flufenamic acid on euglobulin fibrinolytic activity of glass-treated or heated plasma.
Jenks RL; Astrup T
Haemostasis; 1980; 9(4):248-56. PubMed ID: 6156880
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity of salivary euglobulin fractions precipitated at pH 5.9 or 6.4 before and after mixing with blood.
Gersel-Pedersen N
Int J Oral Surg; 1980 Jun; 9(3):190-7. PubMed ID: 6777318
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M
Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792
[TBL] [Abstract][Full Text] [Related]
11. The diurnal increase in euglobulin fibrinolytic activity in women using oral contraceptives and in normal women, and the generation of intrinsic fibrinolytic activity.
Jespersen J
Thromb Haemost; 1986 Oct; 56(2):183-8. PubMed ID: 3101221
[TBL] [Abstract][Full Text] [Related]
12. [Studies on C1 inactivator resistant fibrinolytic activity].
Deguchi A; Kawamura K; Deguchi K; Tamaki S; Tanigawa M; Iwasaki E; Wada H; Murashima S; Nishikawa M; Shirakawa S
Rinsho Byori; 1991 May; 39(5):517-22. PubMed ID: 2072575
[TBL] [Abstract][Full Text] [Related]
13. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.
Urano T; Sumiyoshi K; Pietraszek MH; Takada Y; Takada A
Thromb Haemost; 1991 Oct; 66(4):474-8. PubMed ID: 1796399
[TBL] [Abstract][Full Text] [Related]
14. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives.
Gordon EM; Ratnoff OD; Saito H; Donaldson VH; Pensky J; Jones PK
J Lab Clin Med; 1980 Nov; 96(5):762-9. PubMed ID: 7419960
[TBL] [Abstract][Full Text] [Related]
15. A delaying influence of cryoglobulins in the assessment of euglobulin fibrinolytic activity.
Gram J; Jespersen J; Astrup T
Thromb Res; 1986 Mar; 41(6):781-9. PubMed ID: 2422781
[TBL] [Abstract][Full Text] [Related]
16. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis.
Nordby E; Arnesen H; Andersen P; Godal HC
Scand J Haematol; 1980 Nov; 25(5):407-11. PubMed ID: 7221476
[TBL] [Abstract][Full Text] [Related]
17. [Fibrinolytic activity of the plasma euglobulin fraction in men with coronary disease (under age 60)].
Mamont B; Szczepański M
Kardiol Pol; 1986; 29(10):698-701. PubMed ID: 3586472
[No Abstract] [Full Text] [Related]
18. THE EUGLOBULIN METHOD FOR ESTIMATION OF FIBRINOLYTIC ACTIVITY IN UROKINASE-ACTIVATED PLASMA, AND THE INFLUENCE OF TRASYLOL.
BLIX S
Scand J Clin Lab Invest; 1964; 16():198-200. PubMed ID: 14161857
[No Abstract] [Full Text] [Related]
19. Fibrinolytic activity of euglobulins precipitated from normal or factor XII-deficient plasma in the presence of saturated and unsaturated fatty acids.
Martin NA; Jenks RL; Astrup T
Thromb Res; 1978 Sep; 13(3):509-15. PubMed ID: 741443
[No Abstract] [Full Text] [Related]
20. Evaluation of euglobulin clot lysis time as a screening method for determination of blood plasma fibrinolytic activity after venous occlusion.
Boberg M; Killander A
Acta Med Scand; 1983; 213(4):309-11. PubMed ID: 6613690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
